Related Experiment Video
Updated: Jun 8, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Non-adherence to treatment and concurrent opioid use among people on methadone maintenance treatment using
Nguyen Bich Diep1, Nguyen Thu Trang1, Do Duc Huy1
1Center for Training and Research on Substance Use & HIV, Hanoi Medical University, Hanoi, Viet Nam.
Introduction:
The global rise of concurrent use of opioids and methamphetamine presents challenges to stable methadone maintenance treatment (MMT). We assessed non-adherence to treatment and concurrent opioid use, along with associated factors, among people on MMT using methamphetamine in Vietnam.
Methods:
This analysis utilized baseline data from a randomized clinical trial designed to investigate the effectiveness of various combinations of behavioral evidence-based interventions for methamphetamine use among patients on MMT in Vietnam (STAR-OM R01DA050486). We used data from 498 participants on MMT who self-reported using methamphetamine in the past 30 days and had been in MMT treatment for at least three months. The study determined adherence to MMT through medical record review and assessed concurrent opioid use via urine testing and documented test results in medical records.
Results:
Within the last three months, 145 (29.1 %) did not adhere to MMT, and 212 (42.6 %) concurrently used opioids. Non-adherence to MMT were strongly associated with living at a considerable distance from the clinic (aOR = 1.80, 95 % CI: 1.10-2.90), being HIV positive (aOR = 0.51, 95 % CI: 0.27-0.97), and were marginally associated with using methamphetamine to reduce emotional distress (aOR = 1.56, 95 % CI: 0.99-2.45). Concurrent opioid use was associated with receiving treatment at clinics established during the scale-up period (aOR = 1.80, 95 % CI: 1.13-2.87), an extended duration of treatment at current clinics (aOR = 0.98, 95 % CI: 0.97-0.99), male gender (aOR = 2.09, 95 % CI: 1.05-4.13), and ever injecting methamphetamine (aOR = 1.98, 95 % CI: 1.13-3.46), besides MMT non-adherence (aOR = 2.71, 95 % CI: 1.72-4.29).
Conclusion:
Non-adherence to MMT and concurrent opioid use are prevalent among methamphetamine-using patients on methadone in Vietnam. Alongside well-documented factors influencing methadone program, the rise in methamphetamine adds further complexity to these challenges. Future intervention strategies must address both the underlying issues and methamphetamine use behaviors to effectively improve treatment outcomes.
Trial Registration:
NCT04706624. Registered 13 January 2021. https://clinicaltrials.gov/ct2/show/NCT04706624.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Therapeutic Drug Monitoring: Affecting Factors